Anne Yeakey
Moderna Therapeutics (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Multiple Myeloma Research and Treatments, Asthma and respiratory diseases, Vaccine Coverage and Hesitancy, Influenza Virus Research Studies
Most-Cited Works
- → Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone(2016)155 cited
- → Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma(2016)135 cited
- → DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM)(2020)48 cited
- → DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM).(2020)36 cited
- → Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card(2019)24 cited
- → Effect of raxibacumab on immunogenicity of Anthrax Vaccine Adsorbed: a phase 4, open-label, parallel-group, randomised non-inferiority study(2020)23 cited
- → DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma(2021)17 cited
- → An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005–2011(2013)13 cited
- → Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season(2019)10 cited
- → Dreamm-5: Platform Trial Evaluating Belantamab Mafodotin (a BCMA-directed Immuno-conjugate) in Combination with Novel Agents in Relapsed or Refractory Multiple Myeloma (RRMM)(2019)9 cited